Federal autism advisory board cancels first public meeting since overhaul

The Interagency Autism Coordinating Committee (IACC), a federal committee that advises on autism issues, has canceled its upcoming meeting without providing a reason. This decision comes shortly after reports surfaced that an independent version of the committee was formed in response to Health Secretary Robert F. Kennedy Jr.’s controversial views linking autism and vaccines.

Traditionally, the IACC consisted of researchers with mainstream scientific views and autistic self-advocates. However, concerns were raised when new members appointed to the committee were seen to align with Kennedy’s debunked theories. The committee was scheduled to meet on March 19, marking its first meeting in over a year. While the future meeting date is uncertain, one member hinted on social media that a meeting in April might be possible.

In response to the cancellation of the IACC meeting, the independent group, comprising members like Helen Tager-Flusberg, director of the Center for Autism Research Excellence at Boston University, will proceed with their planned meeting on March 19. The establishment of this independent group demonstrates the importance of maintaining scientific integrity and ensuring that evidence-based practices guide autism research and policy decisions.

The developments surrounding the IACC highlight the ongoing debates and challenges within the autism community. Stakeholders must continue to prioritize evidence-based approaches and prioritize the well-being and support of individuals living with autism. Stay tuned for further updates on this evolving situation.